Diagnostic Accuracy of Serum Hyaluronic Acid, FIBROSpect II, and YKL-40 for Discriminating Fibrosis Stages in Chronic Hepatitis C

Preeti Mehta, Robert Ploutz‐Snyder, Jyotirmoy Nandi, Sekou Rawlins, Schuyler O. Sanderson, Robert A. Levine

The American Journal of Gastroenterology · 2008 · 83 citations · 45 references

Abstract

HA can be utilized as a reliable surrogate marker in distinguishing three clinically relevant stages of fibrosis: absent/minimal, intermediate, and advanced/cirrhosis. HA should be considered as a cost-effective alternative to other serum markers for staging fibrosis and for determining the timing and selection of HCV treatment.

References

45